Yu-Li Lo

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Long Non Coding Rna

Tyrosine Kinase

Epithelial Mesenchymal Transition

Top Venues

Journal of nanobiotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Li Lo, Tse-Yuan Wang, Chun-Jung Chen, Yih-Hsin Chang, Anya Maan-Yuh Lin
Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics 14 (9) (2022)
Yih-Hsin Chang, Shu-Wen Chang, Wei-Ting Hsu, Ching-Ping Yang, Yu-Li Lo, Chun-Jung Chen, Hui-Fang Tsai, Ming-Yuh Shiau
Implication of Adipogenesis-Coupled CRMP2 Functional Profile in Metabolic Homeostasis and Imbalance. Biomedicines 10 (10) (2022)
Yu-Li Lo, Chen-Shen Wang, Yen-Chun Chen, Tse-Yuan Wang, Yih-Hsin Chang, Chun-Jung Chen, Ching-Ping Yang
Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics. Pharmaceutics 12 (8) (2020)
Vivian Juang, Chih-Hsien Chang, Chen-Shen Wang, Hsin-Ell Wang, Yu-Li Lo
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy. Small (Weinheim an der Bergstrasse, Germany) 15 (49) (2019)
Shu-Ting Hong, Huaching Lin, Chen-Shen Wang, Chih-Hsien Chang, Anya Maan-Yuh Lin, James Chih-Hsin Yang, Yu-Li Lo
Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides. Journal of nanobiotechnology 17 (1) (2019)
Guan-Liang Lin, Huei-Ju Ting, Ta-Chien Tseng, Vivian Juang, Yu-Li Lo
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells. PloS one 12 (10) (2017)